SOUTHERN NEIGHBOURHOOD ALTA SEMPER FUND II

Projektträger – zwischengeschaltetes Finanzinstitut

ALTA SEMPER GROWTH II GP

Ort

• Mittelmeerraum

Beschreibung

The project supports the growth of local pharmaceutical and healthcare companies in the Southern Neighbourhood and, to a lesser extent, in Sub-Saharan Africa, through participation in a private equity fund that invests to enhance affordable access to quality disruptive technology and medical services. The project is expected to be strongly aligned with EU trade interests with many portfolio companies that are either expected to source equipment from EU-based suppliers or partner with EU pharmaceutical and MedTech companies to provide regional services.

Ziele

The project supports the growth of local companies and enhances affordable access to quality healthcare products and medical services for final beneficiaries, through investments that will contribute to fulfilling the financing gap of growth capital for pharmaceutical and healthcare companies, predominantly in Northern Africa (Egypt and Morocco), and to a lower extent in Sub-Saharan Africa. This project is not only aligned with the EU-Africa Global Gateway Investment Package, reinforcing the EU's world-leading position as an innovative trade powerhouse in the life sciences and healthcare sector, but also aims to contribute to the 2030 ambition set by the EU under the EU Global Health Strategy and the EU-Africa Global Gateway Investment Package, to strengthen African pharmaceutical systems with regional manufacturing capacities to meet local needs and demand, by promoting research and cross-border innovation in healthcare. The project will support local healthcare system strengthening through private-sector investments into the equitable access to specialised clinical care. The project is expected to contribute to Northern Africa's inclusive economic growth, sustainable and resilient human development, whilst also encouraging the development of the healthcare sector and vital job creation in Northern and Sub-Saharan Africa.

Sektor(en)

• Industrie - Verarbeitendes Gewerbe/Herstellung von Waren
• Gesundheit - Gesundheits- und Sozialwesen

Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

USD 30 million (EUR 26 million)

Gesamtkosten (voraussichtlicher Betrag)

USD 150 million (EUR 132 million)

Umweltaspekte

The project will be implemented in line with the requirements of applicable national and EU environmental and social legislation as well as the relevant EIB Environmental and Social Standards.

Auftragsvergabe

The Bank will require that the project is implemented in accordance with the EIB's Guide to Procurement.

Projektstatus

In Prüfung - 11/03/2025